Senior insider sale
CEO at EDITAS MEDICINE, INC. — senior position signals high conviction
$23.4K
11.60K shares
What this filing means
O'NEILL GILMORE NEIL plans to sell 11.60K shares of EDITAS MEDICINE, INC. valued at approximately $23.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/27/2026ACC: 0001650664-26-000002
DirectorOfficer· CEO
Since Jun 2022
11.60K
Shares to sell
$23.4K
Approx. market value
11.29K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Unit Vesting
Equity Compensation
3/2/2026
11.29KTotal acquired11.29K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/2/2026 | Restricted Stock Unit Vesting Equity Compensation | 11.29K | — |
| Total | 11.29K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
5.60K
Market value
$12.1K
12/3/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
6K
Market value
$11.3K
3/3/2026
Total
Units
11.60K
Value
$23.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/3/2025 | 5.60K | $12.1K | — | Completed |
| Planned — Approximate Date | ||||
3/3/2026 | 6K | $11.3K | NASDAQ | Planned |
| Total | 11.60K | $23.4K | ||